KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $9.59 $9.59 Wednesday, 17th Aug 2022 NLNK stock ended at $9.59. During the day the stock fluctuated 0% from a day low at $9.59 to a day high of $9.59.
90 days $9.59 $9.59
52 weeks $6.15 $11.52

Historical NewLink Genetics Corporation prices

Date Open High Low Close Volume
Jan 29, 2016 $24.60 $25.24 $23.46 $24.36 366 400
Jan 28, 2016 $25.01 $25.86 $23.48 $23.99 520 100
Jan 27, 2016 $26.26 $27.13 $25.05 $25.26 429 700
Jan 26, 2016 $27.44 $27.90 $25.45 $26.38 406 600
Jan 25, 2016 $27.12 $28.48 $26.93 $27.47 506 800
Jan 22, 2016 $27.88 $29.01 $26.70 $27.12 488 900
Jan 21, 2016 $28.16 $29.12 $27.07 $27.16 270 100
Jan 20, 2016 $25.00 $28.83 $24.51 $28.20 586 600
Jan 19, 2016 $26.00 $27.48 $24.78 $25.71 978 300
Jan 15, 2016 $26.30 $26.48 $24.59 $25.61 614 500
Jan 14, 2016 $25.91 $28.50 $24.49 $27.28 609 100
Jan 13, 2016 $28.58 $29.00 $25.53 $25.80 679 000
Jan 12, 2016 $27.76 $29.79 $26.30 $28.12 603 400
Jan 11, 2016 $30.87 $31.04 $26.65 $27.56 604 200
Jan 08, 2016 $30.69 $31.80 $29.89 $30.57 365 500
Jan 07, 2016 $31.76 $31.76 $29.68 $29.72 663 200
Jan 06, 2016 $33.91 $34.14 $31.86 $32.21 460 200
Jan 05, 2016 $34.75 $35.84 $33.65 $34.34 563 000
Click to get the best stock tips daily for free!

About NewLink Genetics Corporation

NewLink Genetics NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer. Its portfolio includes biologic product candidates based on its HyperAcute cellular immunotherapy technology, which is designed to stimulate the human immune system; and small-molecule product candidates that are focused on breaking the immune system's ... NLNK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT